The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.

Jim Mellon plans to take his longevity company Juvenescence public

The company with $170 million private funding has invested in various life extension therapies

29-Sep-2020

Key points from article :

Billionaire Jim Mellon to take his life extension company Juvenescence public in the next 6 to 12 months.

Juvenescence is investing in a wide range of anti-ageing therapies.

The company has identified the investment banks it wants to work with.

But the IPO (initial public offering) appears to be running behind schedule.

Juvenescence has raised about $170 million privately & still has a fair amount of money in the bank.

Several other billionaires have invested in the company. 

“I would think that there’s a good chance that I’m going to live to 100 plus.” - Jim Mellon, British Billionaire.

Mentioned in this article:

Click on resource name for more details.

Jim Mellon

British entrepreneur, author and philanthropist with interests across a number of industries

Juvenescence

Developing therapies against different aging related diseases

Topics mentioned on this page:
Investments